|Day's Range||43.44 - 44.00|
|52 Week Range||36.76 - 45.84|
|PE Ratio (TTM)||45.73|
|Dividend & Yield||1.06 (2.43%)|
|1y Target Est||N/A|
On April 14, 2017, Abbott Laboratories (ABT) agreed to acquire point-of-care diagnostics player Alere (ALR) for an equity value of ~$5.3 billion.
In 1Q17, Abbott Laboratories (ABT) managed to report adjusted earnings per share (or EPS) of nearly $0.48, ~$0.05 higher than analysts' estimated EPS.
The US medical device industry is a global leader. Its market was valued at ~$140 billion for 2016. It represents ~45% of the global market.